volume 488 issue 1 pages 25-37

Genotoxicity of streptonigrin: a review.

ALEJANDRO D. BOLZÁN 1
Martha S. Bianchi 1
1
 
Laboratory of Cytogenetics and Mutagenesis, Instituto Multidisciplinario de Biología Celular (IMBICE), C.C. 403, 1900, La Plata, Argentina.
Publication typeJournal Article
Publication date2001-03-01
scimago Q1
wos Q1
SJR1.882
CiteScore13.1
Impact factor4.2
ISSN13835742, 13882139
Genetics
Health, Toxicology and Mutagenesis
Abstract
Streptonigrin (SN, CAS no. 3930-19-6) is an aminoquinone antitumor antibiotic isolated from cultures of Streptomyces flocculus. This compound is a member of a group of antitumor agents which possess the aminoquinone moiety and that includes also mitomycin C, porfiromycin, actinomycin, rifamycin and geldanamycin. Because of the potential use of SN in clinical chemotherapy, the study of its genotoxicity has considerable practical significance.SN inhibits the synthesis of DNA and RNA, causes DNA strand breaks after reduction with NADH, induces unscheduled DNA synthesis and DNA adducts and inhibits topoisomerase II. At the chromosome level, this antibiotic causes chromosome damage and increases the frequency of sister-chromatid exchanges.SN cleaves DNA in cell-free systems by a mechanism that involves complexing with metal ions and autoxidation of the quinone moiety to semiquinone in the presence of NADH with production of oxygen-derived reactive species. Recent evidence strongly suggests that the clastogenic action of this compound is partially mediated by free radicals. The present review aims at summarizing past and current knowledge concerning the genotoxic effects of SN.
Found 
Found 

Top-30

Journals

1
2
3
4
5
6
7
Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis
7 publications, 5.74%
Molecules
7 publications, 5.74%
Scientific Reports
4 publications, 3.28%
Journal of the American Chemical Society
4 publications, 3.28%
Journal of Bacteriology
4 publications, 3.28%
Bioorganic and Medicinal Chemistry
3 publications, 2.46%
Cancers
3 publications, 2.46%
Journal of Molecular Structure
3 publications, 2.46%
Journal of Organic Chemistry
2 publications, 1.64%
Biomedicines
2 publications, 1.64%
European Journal of Medicinal Chemistry
2 publications, 1.64%
PLoS ONE
2 publications, 1.64%
Mutation Research - Genetic Toxicology and Environmental Mutagenesis
2 publications, 1.64%
Bioorganic and Medicinal Chemistry Letters
2 publications, 1.64%
Bioorganic Chemistry
2 publications, 1.64%
Environmental and Molecular Mutagenesis
2 publications, 1.64%
Chemical Communications
2 publications, 1.64%
European Journal of Phycology
2 publications, 1.64%
Infection and Immunity
2 publications, 1.64%
Proceedings of the National Academy of Sciences of the United States of America
2 publications, 1.64%
Journal of Natural Products
1 publication, 0.82%
Pharmacological Reviews
1 publication, 0.82%
Journal of Cell Science
1 publication, 0.82%
European Journal of Pharmacology
1 publication, 0.82%
Journal of Inorganic Biochemistry
1 publication, 0.82%
World Journal of Microbiology and Biotechnology
1 publication, 0.82%
Applied Sciences (Switzerland)
1 publication, 0.82%
Crystals
1 publication, 0.82%
Pharmaceutics
1 publication, 0.82%
1
2
3
4
5
6
7

Publishers

5
10
15
20
25
30
35
40
Elsevier
36 publications, 29.51%
MDPI
15 publications, 12.3%
American Chemical Society (ACS)
11 publications, 9.02%
Springer Nature
11 publications, 9.02%
Wiley
10 publications, 8.2%
American Society for Microbiology
10 publications, 8.2%
Royal Society of Chemistry (RSC)
6 publications, 4.92%
Taylor & Francis
4 publications, 3.28%
Public Library of Science (PLoS)
2 publications, 1.64%
Proceedings of the National Academy of Sciences (PNAS)
2 publications, 1.64%
IntechOpen
2 publications, 1.64%
American Society for Pharmacology and Experimental Therapeutics
1 publication, 0.82%
The Company of Biologists
1 publication, 0.82%
King Saud University
1 publication, 0.82%
American Society for Biochemistry and Molecular Biology
1 publication, 0.82%
Pleiades Publishing
1 publication, 0.82%
Institute of Biochemistry
1 publication, 0.82%
Oxford University Press
1 publication, 0.82%
Japanese Society for Thermal Medicine
1 publication, 0.82%
Hindawi Limited
1 publication, 0.82%
American Association for Cancer Research (AACR)
1 publication, 0.82%
OOO Zhurnal "Mendeleevskie Soobshcheniya"
1 publication, 0.82%
Cold Spring Harbor Laboratory
1 publication, 0.82%
5
10
15
20
25
30
35
40
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
122
Share
Cite this
GOST |
Cite this
GOST Copy
BOLZÁN A. D., Bianchi M. S. Genotoxicity of streptonigrin: a review. // Mutation Research - Reviews in Mutation Research. 2001. Vol. 488. No. 1. pp. 25-37.
GOST all authors (up to 50) Copy
BOLZÁN A. D., Bianchi M. S. Genotoxicity of streptonigrin: a review. // Mutation Research - Reviews in Mutation Research. 2001. Vol. 488. No. 1. pp. 25-37.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1016/S1383-5742(00)00062-4
UR - https://doi.org/10.1016/S1383-5742(00)00062-4
TI - Genotoxicity of streptonigrin: a review.
T2 - Mutation Research - Reviews in Mutation Research
AU - BOLZÁN, ALEJANDRO D.
AU - Bianchi, Martha S.
PY - 2001
DA - 2001/03/01
PB - Elsevier
SP - 25-37
IS - 1
VL - 488
PMID - 11223403
SN - 1383-5742
SN - 1388-2139
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{2001_BOLZÁN,
author = {ALEJANDRO D. BOLZÁN and Martha S. Bianchi},
title = {Genotoxicity of streptonigrin: a review.},
journal = {Mutation Research - Reviews in Mutation Research},
year = {2001},
volume = {488},
publisher = {Elsevier},
month = {mar},
url = {https://doi.org/10.1016/S1383-5742(00)00062-4},
number = {1},
pages = {25--37},
doi = {10.1016/S1383-5742(00)00062-4}
}
MLA
Cite this
MLA Copy
BOLZÁN, ALEJANDRO D., and Martha S. Bianchi. “Genotoxicity of streptonigrin: a review..” Mutation Research - Reviews in Mutation Research, vol. 488, no. 1, Mar. 2001, pp. 25-37. https://doi.org/10.1016/S1383-5742(00)00062-4.